法医学杂志 ›› 2021, Vol. 37 ›› Issue (6): 763-775.DOI: 10.12116/j.issn.1004-5619.2021.310202
所属专题: 合成毒品的法医毒理学研究
洪仕君1(), 沈宝玉1, 孙荣基2, 杨根梦1, 段春梅2, 聂倩云1, 张从斌2, 董文娟1, 于浩1, 王上1, 刘鹏亮1, 闻品渊2(
), 李利华1(
)
收稿日期:
2021-02-01
发布日期:
2021-12-25
出版日期:
2021-12-28
通讯作者:
闻品渊,李利华
作者简介:
闻品渊,男,主要从事药物依赖防治及相关研究;E-mail:773597347@qq.com基金资助:
Shi-jun HONG1(), Bao-yu SHEN1, Rong-ji SUN2, Gen-meng YANG1, Chun-mei DUAN2, Qian-yun NIE1, Cong-bin ZHANG2, Wen-juan DONG1, Hao YU1, Shang WANG1, Peng-liang LIU1, Pin-yuan WEN2(
), Li-hua LI1(
)
Received:
2021-02-01
Online:
2021-12-25
Published:
2021-12-28
Contact:
Pin-yuan WEN,Li-hua LI
摘要:
毒品问题是世界性的重大社会公共安全问题,毒品滥用给经济发展、社会稳定和人民健康带来巨大威胁。近年来,以甲基苯丙胺为代表的合成毒品滥用已超过吗啡、海洛因、氯胺酮等传统毒品,成为世界范围内滥用最多的毒品之一。为解决毒品滥用这一重大社会公共安全问题,开展全方位、多层次的毒品相关问题的科学研究具有重要的理论价值和实践意义。本文立足当前毒品滥用形势,对合成毒品甲基苯丙胺滥用的流行病学特征、监测技术、毒性损害基础研究、戒断药物筛选、相关的临床共病以及检测技术等方面的研究进展进行综述,全面展现甲基苯丙胺滥用相关问题的发展趋势。
中图分类号:
洪仕君, 沈宝玉, 孙荣基, 杨根梦, 段春梅, 聂倩云, 张从斌, 董文娟, 于浩, 王上, 刘鹏亮, 闻品渊, 李利华. 甲基苯丙胺滥用现状及相关研究进展[J]. 法医学杂志, 2021, 37(6): 763-775.
Shi-jun HONG, Bao-yu SHEN, Rong-ji SUN, Gen-meng YANG, Chun-mei DUAN, Qian-yun NIE, Cong-bin ZHANG, Wen-juan DONG, Hao YU, Shang WANG, Peng-liang LIU, Pin-yuan WEN, Li-hua LI. Current Situation of Methamphetamine Abuse and Related Research Progress[J]. Journal of Forensic Medicine, 2021, 37(6): 763-775.
1 | United Nations Office on Drugs and Crime (UNODC). World drug report 2021[EB/OL]. (2021-06-24)[2021-12-29]. . |
2 | 2020年中国毒情形势报告[EB/OL].(2021-07-16)[2021-12-29]. . |
Drug situation in China (2020)[EB/OL]. (2021-07-16)[2021-12-29]. . | |
3 | KOHNO M, BESTE C, PILHATSCH M. Editorial: The global methamphetamine problem: Approaches to elucidate the neurobiology, epidemiology, and therapeutic effectiveness[J]. Front Psychiatry,2020,11:850. doi:10.3389/fpsyt.2020.00850. |
4 | SPIVAK B, SHEPHERD S, BORSCHMANN R, et al. Crystalline methamphetamine (ice) use prior to youth detention: A forensic concern or a public health issue?[J]. PLoS One,2020,15(5):e0229389. doi:10.1371/journal.pone.0229389. |
5 | 王延涛. 新冠疫情中境外毒品交易的变化及应对措施[J].犯罪与改造研究,2020(12):2. |
WANG Y T. Changes and countermeasures of overseas drug trade during the COVID-19 pandemic[J]. Fanzui Yu Gaizao Yanjiu,2020(12):2. | |
6 | DAUGHTON C G. Pharmaceuticals and personal care products in the environment: Scientific and regulatory issues[M]. Washington, D.C.: American Chenmical Society,2001:348-364. |
7 | 原帅,向平,于治国,等. 污水中毒品分析方法研究进展[J].中国司法鉴定,2020(4):23-30. doi:10.3969/j.issn.1671-2072.2020.04.004. |
YUAN S, XIANG P, YU Z G, et al. Advances in the determination of illicit drugs in wastewater[J]. Zhongguo Sifa Jianding,2020(4):23-30. | |
8 | GONZÁLEZ-MARIÑO I, BAZ-LOMBA J A, ALY-GIZAKIS N A, et al. Spatio-temporal assessment of illicit drug use at large scale: Evidence from 7 years of international wastewater monitoring[J]. Addiction,2020,115(1):109-120. doi:10.1111/add.14767. |
9 | LAI F Y, O’BRIEN J, THAI P K, et al. Trends in methamphetamine residues in wastewater in metropolitan and regional cities in south-east Queensland,2009-2015[J]. Med J Aust,2016,204(4):151-152. doi:10.5694/mja15.01054. |
10 | WILKINS C, LAI F Y, O’BRIEN J, et al. Comparing methamphetamine, MDMA, cocaine, codeine and methadone use between the Auckland region and four Australian states using wastewater-based epidemiology (WBE)[J]. N Z Med J,2018,131(1478):12-20. |
11 | KIM K Y, LAI F Y, KIM H Y, et al. The first application of wastewater-based drug epidemiology in five South Korean cities[J]. Sci Total Environ,2015,524/525:440-446. doi:10.1016/j.scitotenv.2015.04.065. |
12 | ZAREI S, SALIMI Y, REPO E, et al. A global systematic review and meta-analysis on illicit drug consumption rate through wastewater-based epide-miology[J]. Environ Sci Pollut Res Int,2020,27(29):36037-36051. doi:10.1007/s11356-020-09818-6. |
13 | 吕宪祥,曾岚,刘志民,等. 药物滥用监测与监测数据分析[J].中国药理学与毒理学杂志,1997,11(2):157-158. |
LÜ X X, ZENG L, LIU Z M, et al. Drug abuse monitoring and data analysis[J]. Zhongguo Yaolixue Yu Dulixue Zazhi,1997,11(2):157-158. | |
14 | LAI F Y, BRUNO R, LEUNG H W, et al. Estimating daily and diurnal variations of illicit drug use in Hong Kong: A pilot study of using wastewater analysis in an Asian metropolitan city[J]. Forensic Sci Int,2013,233(1/2/3):126-132. doi:10.1016/j.forsciint.2013.09.003. |
15 | KHAN U, NUIJS A L N VAN, LI J, et al. Application of a sewage-based approach to assess the use of ten illicit drugs in four Chinese megacities[J]. Sci Total Environ,2014,487:710-721. doi:10.1016/j.scitotenv.2014.01.043. |
16 | 孙荣基,吴天辉,孟怡然,等. 通过污水分析估计昆明市的甲基苯丙胺滥用情况[J].中国药物滥用防治杂志,2019,25(6):317-321. doi:10.15900/j.cnki.zylf1995.2019.06.002. |
SUN R J, WU T H, MENG Y R, et al. Estimation of methamphetamine use in Kunming by wastewater analysis[J]. Zhongguo Yaowu Lanyong Fangzhi Zazhi,2019,25(6):317-321. | |
17 | SHAO X T, LIU Y S, TAN D Q, et al. Methamphetamine use in typical Chinese cities evaluated by wastewater-based epidemiology[J]. Environ Sci Pollut Res Int,2020,27(8):8157-8165. doi:10.1007/s11356-019-07504-w. |
18 | DU P, LI K, LI J, et al. Methamphetamine and ketamine use in major Chinese cities, a nationwide reconnaissance through sewage-based epidemiology[J]. Water Res,2015,84:76-84. doi:10.1016/j.watres.2015.07.025. |
19 | 王强. 环境污水监测技术对深圳基层毒品防控的借鉴及启示[J].环境科学与管理,2019,44(5):113-117. doi:10.3969/j.issn.1673-1212.2019.05.027. |
WANG Q. Application and enlightenment of environmental sewage monitoring technique to grassroots illicit drugs prevention and control[J]. Huanjing Kexue Yu Guanli,2019,44(5):113-117. | |
20 | 杨根梦,陈逊,曾晓锋. 甲基苯丙胺诱导神经细胞自噬的研究进展[J].中国药理学通报,2016,32(10):1341-1344. doi:10.3969/j.issn.1001-1978.2016.10.003. |
YANG G M, CHEN X, ZENG X F. Research progress of methamphetamine inducing nerve cell’s autophagy[J]. Zhongguo Yaolixue Tongbao,2016,32(10):1341-1344. | |
21 | CRUICKSHANK C C, DYER K R. A review of the clinical pharmacology of methamphetamine[J]. Addiction,2009,104(7):1085-1099. doi:10.1111/j.1360-0443.2009.02564.x. |
22 | 刘溪,代振凤,蒲小平. 甲基苯丙胺成瘾机制进展[J].中国新药杂志,2017,26(21):2541-2545. |
LIU X, DAI Z F, PU X P. Advances in the mechanism of methamphetamine addiction[J]. Zhongguo Xinyao Zazhi,2017,26(21):2541-2545. | |
23 | 翁传波,钱若兵,傅先明. 甲基苯丙胺成瘾机制的研究进展[J].国际神经病学神经外科学杂志,2012,39(1):65-69. doi:10.16636/j.cnki.jinn.2012.01.022. |
WENG C B, QIAN R B, FU X M. Research progress on the mechanism of methamphetamine addiction[J]. Guoji Shengjingbingxue Shengjingwaike-xue Zazhi,2012,39(1):65-69. | |
24 | PIMENTEL E, SIVALINGAM K, DOKE M, et al. Effects of drugs of abuse on the blood-brain barrier: A brief overview[J]. Front Neurosci,2020,14:513. doi:10.3389/fnins.2020.00513. |
25 | HAWKINS B T, DAVIS T P. The blood-brain barrier/neurovascular unit in health and disease[J]. Pharmacol Rev,2005,57(2):173-185. doi:10.1124/pr.57.2.4. |
26 | ABBOTT N J, RÖNNBÄCK L, HANSSON E. Astrocyte-endothelial interactions at the blood-brain barrier[J]. Nat Rev Neurosci,2006,7(1):41-53. doi:10.1038/nrn1824. |
27 | 郄晓娟. 甲基苯丙胺诱导血脑屏障损伤的内质网应激机制研究[D].石家庄:河北医科大学,2017. |
QIE X J. Endoplasmic reticulum mechanism in methamphetamine-induced blood-brain barrier[D]. Shijiazhuang: Hebei Medical University,2017. | |
28 | XIAO N, ZHANG F, ZHU B, et al. CDK5-mediated tau accumulation triggers methamphetamine-induced neuronal apoptosis via endoplasmic reticulum-as-sociated degradation pathway[J]. Toxicol Lett,2018,292:97-107. doi:10.1016/j.toxlet.2018.04.027. |
29 | WONGPRAYOON P, GOVITRAPONG P. Melatonin protects SH-SY5Y neuronal cells against metham-phetamine-induced endoplasmic reticulum stress and apoptotic cell death[J]. Neurotox Res,2017,31(1):1-10. doi:10.1007/s12640-016-9647-z. |
30 | CHEN C, QINCAO L, XU J, et al. Role of PUMA in methamphetamine-induced neuronal apoptosis[J]. Toxicol Lett,2016,240(1):149-160. doi:10.1016/j.toxlet.2015.10.020. |
31 | PARK J H, SEO Y H, JANG J H, et al. Asiatic acid attenuates methamphetamine-induced neuroinflammation and neurotoxicity through blocking of NF-kB/STAT3/ERK and mitochondria-mediated apoptosis pathway[J]. J Neuroinflammation,2017,14(1):240. doi:10.1186/s12974-017-1009-0. |
32 | XIONG K, LIAO H, LONG L, et al. Necroptosis contributes to methamphetamine-induced cytotoxi-city in rat cortical neurons[J]. Toxicol In Vitro,2016,35:163-168. doi:10.1016/j.tiv.2016.06.002. |
33 | FOROUGHI K, KHAKSARI M, RAHMATI M, et al. Apelin-13 protects PC12 cells against metham-phetamine-induced oxidative stress, autophagy and apoptosis[J]. Neurochem Res,2019,44(9):2103-2112. doi:10.1007/s11064-019-02847-9. |
34 | MA J, WAN J, MENG J, et al. Methamphetamine induces autophagy as a pro-survival response against apoptotic endothelial cell death through the Kappa opioid receptor[J]. Cell Death Dis,2014,5(3):e1099. doi:10.1038/cddis.2014.64. |
35 | ZHANG Y, SHEN K, BAI Y, et al. Mir143-BBC3 cascade reduces microglial survival via interplay between apoptosis and autophagy: Implications for methamphetamine-mediated neurotoxicity[J]. Autophagy,2016,12(9):1538-1559. doi:10.1080/15548627.2016.1191723. |
36 | LI J, ZHU L, SU H, et al. Regulation of miR-128 in the nucleus accumbens affects metham-phetamine-induced behavioral sensitization by modulating proteins involved in neuroplasticity[J]. Addict Biol,2021,26(1):e12881. doi:10.1111/adb.12881. |
37 | LIU P, LEI G, CHU Z, et al. The role of HINT1 in methamphetamine-induced behavioral sensitization[J]. Psychopharmacology (Berl),2020,237(8):2345-2351. doi:10.1007/s00213-020-05538-4. |
38 | CUBELLS J F, RAYPORT S, RAJENDRAN G, et al. Methamphetamine neurotoxicity involves vacuo-lation of endocytic organelles and dopamine-depen-dent intracellular oxidative stress[J]. J Neurosci,1994,14(4):2260-2271. doi:10.1523/JNEUROSCI.14-04-02260.1994. |
39 | TOBOREK M, SEELBACH M J, RASHID C S, et al. Voluntary exercise protects against methamphe-tamine-induced oxidative stress in brain microvasculature and disruption of the blood-brain barrier[J]. Mol Neurodegener,2013,8:22. doi:10.1186/1750-1326-8-22. |
40 | HANSEN J P, RIDDLE E L, SANDOVAL V, et al. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: Mechanisms and implications for neurotoxicity[J]. J Pharmacol Exp Ther,2002,300(3):1093-1100. doi:10.1124/jpet.300.3.1093. |
41 | CADET J L, BRANNOCK C. Free radicals and the pathobiology of brain dopamine systems[J]. Neurochem Int,1998,32(2):117-131. doi:10.1016/s0197-0186(97)00031-4. |
42 | BROWN J M, YAMAMOTO B K. Effects of amphetamines on mitochondrial function: Role of free radicals and oxidative stress[J]. Pharmacol Ther,2003,99(1):45-53. doi:10.1016/s0163-7258(03)00052-4. |
43 | DENG X, CAI N S, MCCOY M T, et al. Metham-phetamine induces apoptosis in an immortalized rat striatal cell line by activating the mitochondrial cell death pathway[J]. Neuropharmacology,2002,42(6):837-845. doi:10.1016/s0028-3908(02)00034-5. |
44 | CUNHA-OLIVEIRA T, REGO A C, CARDOSO S M, et al. Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine[J]. Brain Res,2006,1089(1):44-54. doi:10.1016/j.brainres.2006.03.061. |
45 | SAHA K, SAMBO D, RICHARDSON B D, et al. Intracellular methamphetamine prevents the do-pamine-induced enhancement of neuronal firing[J]. J Biol Chem,2014,289(32):22246-22257. doi:10.1074/jbc.M114.563056. |
46 | SUN D, YUE Q, GUO W, et al. Neuroprotection of resveratrol against neurotoxicity induced by me-thamphetamine in mouse mesencephalic dopaminergic neurons[J]. Biofactors,2015,41(4):252-260. doi:10.1002/biof.1221. |
47 | WARREN M W, ZHENG W, KOBEISSY F H, et al. Calpain- and caspase-mediated αII-spectrin and tau proteolysis in rat cerebrocortical neuronal cultures after ecstasy or methamphetamine exposure[J]. Int J Neuropsychopharmacol,2007,10(4):479-489. doi:10.1017/s1461145706007061. |
48 | WEISSMAN B A, JONES C L, LIU Q, et al. Activation and inactivation of neuronal nitric oxide synthase: Characterization of Ca2+-dependent [125I]Cal-modulin binding[J]. Eur J Pharmacol,2002,435(1):9-18. doi:10.1016/S0014-2999(01)01560-6. |
49 | BROWN G C, COOPER C E. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase[J]. FEBS Lett,1994,356(2/3):295-298. doi:10.1016/0014-5793(94)01290-3. |
50 | KIM B, YUN J, PARK B. Methamphetamine-induced neuronal damage: Neurotoxicity and neuroinflammation[J]. Biomol Ther (Seoul),2020,28(5):381-388. doi:10.4062/biomolther.2020.044. |
51 | SHAERZADEH F, STREIT W J, HEYSIEAT-TALAB S, et al. Methamphetamine neurotoxicity, microglia, and neuroinflammation[J]. J Neuroinflammation,2018,15(1):341. doi:10.1186/s12974-018-1385-0. |
52 | 赵蕾. miR-143/PUMA引起NLRP3活化在甲基苯丙胺致神经炎性反应中的作用[D].南京:东南大学,2018. |
ZHAO L. NLRP3 activation regulated by miR-143/PUMA: Implications for methamphetamine-induced neuroinflammatory response[D]. Nanjing: Southeast University,2018. | |
53 | HEINZERLING K G, SHOPTAW S, PECK J A, et al. Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence[J]. Drug Alcohol Depend,2006,85(3):177-184. doi:10.1016/j.drugalcdep.2006.03.019. |
54 | KOHNO M, DENNIS L E, MCCREADY H, et al. A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder[J]. Drug Alcohol Depend,2018,192:186-192. doi:10.1016/j.drugalcdep.2018.07.045. |
55 | RUNARSDOTTIR V, HANSDOTTIR I, TYR-FINGSSON T, et al. Extended-release injectable naltrexone (XR-NTX) with intensive psychosocial therapy for amphetamine-dependent persons seeking treatment: A placebo-controlled trial[J]. J Addict Med,2017,11(3):197-204. doi:10.1097/adm.0000000000000297. |
56 | COFFIN P O, SANTOS G M, HERN J, et al. Extended-release naltrexone for methamphetamine dependence among men who have sex with men: A randomized placebo-controlled trial[J]. Addiction,2018,113(2):268-278. doi:10.1111/add.13950. |
57 | FARAHZADI M H, MOAZEN-ZADEH E, RA-ZAGHI E, et al. Riluzole for treatment of men with methamphetamine dependence: A randomized, double-blind, placebo-controlled clinical trial[J]. J Psychopharmacol,2019,33(3):305-315. doi:10.1177/0269881118817166. |
58 | MORABBI M J, RAZAGHI E, MOAZEN-ZADEH E, et al. Pexacerfont as a CRF1 antagonist for the treatment of withdrawal symptoms in men with heroin/methamphetamine dependence: A randomized, double-blind, placebo-controlled clinical trial[J]. Int Clin Psychopharmacol,2018,33(2):111-119. doi:10.1097/YIC.0000000000000200. |
59 | KONGSAKON R, PAPADOPOULOS K I, SA-GUANSIRITHAM R. Mirtazapine in amphetamine detoxification: A placebo-controlled pilot study[J]. Int Clin Psychopharmacol,2005,20(5):253-256. doi:10.1097/01.yic.0000166815.83017.d8. |
60 | CRUICKSHANK C C, MONTEBELLO M E, DYER K R, et al. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal[J]. Drug Alcohol Rev,2008,27(3):326-333. doi:10.1080/09595230801935672. |
61 | ANDERSON A L, LI S H, MARKOVA D, et al. Bupropion for the treatment of methamphetamine dependence in non-daily users: A randomized, double-blind, placebo-controlled trial[J]. Drug Alcohol Depend,2015,150:170-174. doi:10.1016/j.drugalcdep.2015.01.036. |
62 | ELKASHEF A M, RAWSON R A, ANDERSON A L, et al. Bupropion for the treatment of metham-phetamine dependence[J]. Neuropsychopharmacology,2008,33(5):1162-1170. doi:10.1038/sj.npp.1301481. |
63 | HEINZERLING K G, SWANSON A N, HALL T M, et al. Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use[J]. Addiction,2014,109(11):1878-1886. doi:10.1111/add.12636. |
64 | SCHOTTENFELD R S, CHAWARSKI M C, SO-FUOGLU M, et al. Atomoxetine for amphetamine-type stimulant dependence during buprenorphine treatment: A randomized controlled trial[J]. Drug Alcohol Depend,2018,186:130-137. doi:10.1016/j.drugalcdep.2018.01.017. |
65 | COFFIN P O, SANTOS G M, DAS M, et al. Ari-piprazole for the treatment of methamphetamine dependence: A randomized, double-blind, placebo-con-trolled trial[J]. Addiction,2013,108(4):751-761. doi:10.1111/add.12073. |
66 | TIIHONEN J, KUOPPASALMI K, FÖHR J, et al. A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence[J]. Am J Psychiatry,2007,164(1):160-162. doi:10.1176/ajp.2007.164.1.160. |
67 | SU H, SUN T, WANG X, et al. Levo-tetrahy-dropalmatine attenuates methamphetamine reward behavior and the accompanying activation of ERK phosphorylation in mice[J]. Neurosci Lett,2020,714:134416. doi:10.1016/j.neulet.2019.134416. |
68 | WANG Y, GU Y H, LIU M, et al. Fluoxetine protects against methamphetamine‑induced lung inflammation by suppressing oxidative stress through the SERT/p38 MAPK/Nrf2 pathway in rats[J]. Mol Med Rep,2017,15(2):673-680. doi:10.3892/mmr.2016.6072. |
69 | WU J, ZHU D, ZHANG J, et al. Melatonin treatment during the incubation of sensitization attenuates methamphetamine-induced locomotor sensitization and MeCP2 expression[J]. Prog Neuropsychopharmacol Biol Psychiatry,2016,65:145-152. doi:10.1016/j.pnpbp.2015.09.008. |
70 | WANG Y, WANG X, CHEN J, et al. Melatonin pretreatment attenuates acute methamphetamine-induced aggression in male ICR mice[J]. Brain Res,2019,1715:196-202. doi:10.1016/j.brainres.2019.04.002. |
71 | LWIN T, YANG J L, NGAMPRAMUAN S, et al. Melatonin ameliorates methamphetamine-induced cognitive impairments by inhibiting neuroinflammation via suppression of the TLR4/MyD88/NFκB signaling pathway in the mouse hippocampus[J]. Prog Neuropsychopharmacol Biol Psychiatry,2021,111:110109. doi:10.1016/j.pnpbp.2020.110109. |
72 | KANTHASAMY K, GORDON R, JIN H, et al. Neuroprotective effect of resveratrol against metham-phetamine-induced dopaminergic apoptotic cell death in a cell culture model of neurotoxicity[J]. Curr Neuropharmacol,2011,9(1):49-53. doi:10.2174/157015911795017353. |
73 | MA C L, LI L, YANG G M, et al. Neuroprotective effect of gastrodin in methamphetamine-induced apoptosis through regulating cAMP/PKA/CREB pathway in cortical neuron[J]. Hum Exp Toxicol,2020,39(8):1118-1129. doi:10.1177/0960327120911438. |
74 | YANG G M, LI L, XUE F L, et al. The potential role of PKA/CREB signaling pathway concerned with gastrodin administration on methamphe-tamine-induced conditioned place preference rats and SH-SY5Y cell line[J]. Neurotox Res,2020,37(4):926-935. doi:10.1007/s12640-019-00150-7. |
75 | 薛凤麟,洪仕君,曾晓峰,等. 天麻素注射液通过调节背侧纹状体miR-30a表达改善大鼠甲基苯丙胺成瘾的实验研究[J].中药药理与临床,2020,36(1):85-89. doi:10.13412/j.cnki.zyyl.2020.01.009. |
XUE F L, HONG S J, ZENG X F, et al. Effect of gastrodin injection on improving methamphe-tamine addiction in rats by regulating the expression of miR-30a in dorsal striatum[J]. Zhongyao Yaoli Yu Linchuang,2020,36(1):85-89. | |
76 | 黄兆奎,石振金,吴亚梅,等. 甲基苯丙胺不同给药时程及天麻素的干预对建立大鼠条件性位置偏爱模型的影响[J].昆明医科大学学报,2019,40(3):1-5. doi:10.3969/j.issn.1003-4706.2019.03.001. |
HUANG Z K, SHI Z J, WU Y M, et al. Establishment of the methamphetamine induced rat conditioned place preference model and the intervention effect of gastrodin[J]. Kunming Yike Daxue Xuebao,2019,40(3):1-5. | |
77 | DANG D K, SHIN E J, KIM D J, et al. Ginseno-side Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor[J]. J Neuroinflammation,2018,15(1):52. doi:10.1186/s12974-018-1087-7. |
78 | SHIN E J, SHIN S W, NGUYEN T T L, et al. Ginsenoside Re rescues methamphetamine-induced oxidative damage, mitochondrial dysfunction, micro-glial activation, and dopaminergic degeneration by inhibiting the protein kinase Cδ gene[J]. Mol Neurobiol,2014,49(3):1400-1421. doi:10.1007/s12035-013-8617-1. |
79 | ZHU C, LIU W, LUO C, et al. Inhibiting effects of rhynchophylline on methamphetamine-dependent zebrafish are related with the expression of tyrosine hydroxylase (TH)[J]. Fitoterapia,2017,117:47-51. doi:10.1016/j.fitote.2017.01.001. |
80 | 陈毅飞,彭菊,房淼,等. 钩藤碱对甲基苯丙胺依赖斑马鱼行为学的影响及机制[J].南方医科大学学报,2016,36(11):1541-1545. doi:10.3969/j.issn.1673-4254.2016.11.16. |
CHEN Y F, PENG J, FANG M, et al. Effect of rhynchophylline on behaviors of methamphetamine-dependent zebrafish and the mechanism[J]. Nanfang Yike Daxue Xuebao,2016,36(11):1541-1545. | |
81 | LI J, LIU W, PENG Q, et al. Effect of rhynchophylline on conditioned place preference on expression of NR2B in methamphetamine-dependent mice[J]. Biochem Biophys Res Commun,2014,452(3):695-700. doi:10.1016/j.bbrc.2014.08.127. |
82 | XU D D, HOEVEN R, RONG R, et al. Rhynchophylline protects cultured rat neurons against methamphetamine cytotoxicity[J]. Evid Based Complementary Altern Med,2012,2012:636091. doi:10.1155/2012/636091. |
83 | GONZALEZ-CUEVAS G, MARTIN-FARDON R, KERR T M, et al. Unique treatment potential of cannabidiol for the prevention of relapse to drug use: Preclinical proof of principle[J]. Neuropsychopharmacology,2018,43(10):2036-2045. doi:10.1038/s41386-018-0050-8. |
84 | HAY G L, BARACZ S J, EVERETT N A, et al. Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methampheta-mine-primed relapse in rats[J]. J Psychopharmacol,2018,32(12):1369-1378. doi:10.1177/0269881118799954. |
85 | YANG G, LIU L, ZHANG R, et al. Cannabidiol attenuates methamphetamine-induced conditioned place preference via the Sigma1R/AKT/GSK-3β/CREB signaling pathway in rats[J]. Toxicol Res (Camb),2020,9(3):202-211. doi:10.1093/toxres/tfaa021. |
86 | 张文怡. 运动影响甲基苯丙胺戒断者ΔFosB和c-Fos血浆水平对渴求程度的改善作用[D].长沙:湖南师范大学,2020. |
ZHANG W Y. Movement influence methampheta-mine withdrawal is ΔFosB plasma levels and c-Fos role on the improvement of the degree of desire[D]. Changsha: Hunan Normal University,2020. | |
87 | 李夏雯. 有氧运动对甲基苯丙胺戒断者情绪记忆的影响及机制研究[D].上海:上海体育学院,2020. |
LI X W. The mechanism in the effect of aerobic exercise on emotional memory in methamphetamine abstainers[D]. Shanghai: Shanghai University of Sport,2020. | |
88 | 刘瑞雯. 太极拳对上海市女甲基苯丙胺成瘾者执行功能康复效果的研究[D].上海:上海体育学院,2019. |
LIU R W. Study on the effect of Tai Chi on functional rehabilitation of female methamphetamine addicts in Shanghai[D]. Shanghai: Shanghai University of Sport,2019. | |
89 | SU H, LIU Y, YIN D, et al. Neuroplastic changes in resting-state functional connectivity after rTMS intervention for methamphetamine craving[J]. Neuropharmacology,2020,175:108177. doi:10.1016/j.neuropharm.2020.108177. |
90 | XU X, DING X, CHEN L, et al. The transcranial direct current stimulation over prefrontal cortex combined with the cognitive training reduced the cue-induced craving in female individuals with methamphetamine use disorder: A randomized controlled trial[J]. J Psychiatr Res,2021,134:102-110. doi:10.1016/j.jpsychires.2020.12.056. |
91 | SCHNEIDER F H. Amphetamine-induced exocytosis of catecholamines from the cow adrenal medulla[J]. J Pharmacol Exp Ther,1972,183(1):80-89. |
92 | COURTNEY K E, RAY L A. Methamphetamine: An update on epidemiology, pharmacology, clinical phenomenology, and treatment literature[J]. Drug Alcohol Depend,2014,143:11-21. doi:10.1016/j.dru galcdep.2014.08.003. |
93 | RAWSON R A, CONDON T P. Why do we need an Addiction supplement focused on methampheta-mine?[J]. Addiction,2007,102(S1):1-4. doi:10.1111/j.1360-0443.2006.01781.x. |
94 | HSIEH J H, STEIN D J, HOWELLS F M. The neurobiology of methamphetamine induced psychosis[J]. Front Hum Neurosci,2014,8:537. doi:10.3389/fnhum.2014.00537. |
95 | MAHONEY J J3RD, THOMPSON-LAKE D G Y, COOPER K,et al. A comparison of impulsivity, depressive symptoms, lifetime stress and sensation seeking in healthy controls versus participants with cocaine or methamphetamine use disorders[J]. J Psychopharmacol,2015,29(1):50-56. doi:10.1177/0269881114560182. |
96 | JAVANBAKHT M, SHOPTAW S, RAGSDALE A, et al. Depressive symptoms and substance use: Changes overtime among a cohort of HIV-positive and HIV-negative MSM[J]. Drug Alcohol Depend,2020,207:107770. doi:10.1016/j.drugalcdep.2019.107770. |
97 | ZHANG J, XIE Y, SU H, et al. Prevalence and correlates of depressive symptoms during early me-thamphetamine withdrawal in Han Chinese population[J]. Drug Alcohol Depend,2014,142:191-196. doi:10.1016/j.drugalcdep.2014.06.021. |
98 | KAY-LAMBKIN F J, BAKER A L, LEE N M, et al. The influence of depression on treatment for methamphetamine use[J]. Med J Aust,2011,195(3):S38-S43. doi:10.5694/j.1326-5377.2011.tb03264.x. |
99 | MCKETIN R, LUBMAN D I, LEE N M, et al. Major depression among methamphetamine users entering drug treatment programs[J]. Med J Aust,2011,195(3):S51-S55. doi:10.5694/j.1326-5377.2011.tb03266.x. |
100 | MARAZZITI D, BARONI S, PICCHETTI M, et al. Mitochondrial alterations and neuropsychiatric disorders[J]. Curr Med Chem,2011,18(30):4715-4721. doi:10.2174/092986711797379221. |
101 | SUNG Y H, YURGELUN-TODD D A, SHI X F, et al. Decreased frontal lobe phosphocreatine levels in methamphetamine users[J]. Drug Alcohol Depend,2013,129(1/2):102-109. doi:10.1016/j.drugalcdep.2012.09.015. |
102 | HELLEM T L, SUNG Y H, SHI X F, et al. Crea-tine as a novel treatment for depression in females using methamphetamine: A pilot study[J]. J Dual Diagn,2015,11(3/4):189-202. doi:10.1080/15504263.2015.1100471. |
103 | SILVERSTEIN P S, SHAH A, GUPTE R, et al. Me-thamphetamine toxicity and its implications during HIV-1 infection[J]. J Neurovirol,2011,17(5):401-415. doi:10.1007/s13365-011-0043-4. |
104 | PENDYALA G, BUESCHER J L, FOX H S. Methamphetamine and inflammatory cytokines increase neuronal Na+/K+-ATPase isoform 3: Relevance for HIV associated neurocognitive disorders[J]. PLoS One,2012,7(5):e37604. doi:10.1371/journal.pone.0037604. |
105 | MATA M M, NAPIER T C, GRAVES S M, et al. Methamphetamine decreases CD4 T cell frequency and alters pro-inflammatory cytokine production in a model of drug abuse[J]. Eur J Pharmacol,2015,752:26-33. doi:10.1016/j.ejphar.2015.02.002. |
106 | WANG X, WANG Y, YE L, et al. Modulation of intracellular restriction factors contributes to metham-phetamine-mediated enhancement of acquired immune deficiency syndrome virus infection of macrophages[J]. Curr HIV Res,2012,10(5):407-414. doi:10.2174/157016212802138797. |
107 | BELLO K J, MESNER O, O’BRYAN T A, et al. Factors associated with 10 years of continuous viral load suppression on HAART[J]. BMC Infect Dis,2016,16:351. doi:10.1186/s12879-016-1677-x. |
108 | PARSONS J T, KOWALCZYK W J, BOTSKO M, et al. Aggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men[J]. AIDS Behav,2013,17(4):1478-1487. doi:10.1007/s10461-013-0463-7. |
109 | FAIRBAIRN N, KERR T, MILLOY M J, et al. Crystal methamphetamine injection predicts slower HIV RNA suppression among injection drug users[J]. Addict Behav,2011,36(7):762-763. doi:10.1016/j.addbeh.2011.02.001. |
110 | ROBINSON J D, HOWARD C D, PASTUZYN E D, et al. Methamphetamine-induced neurotoxicity disrupts pharmacologically evoked dopamine transients in the dorsomedial and dorsolateral striatum[J]. Neurotox Res,2014,26(2):152-167. doi:10.1007/s12640-014-9459-y. |
111 | PREGELJC D, TEODORESCU-PERIJOC D, VIANE-LLO R, et al. How important is the use of cocaine and amphetamines in the development of parkinson disease? A computational study[J]. Neurotox Res,2020,37(3):724-731. doi:10.1007/s12640-019-00149-0. |
112 | LAPPIN J M, DARKE S, FARRELL M. Methamphe-tamine use and future risk for Parkinson’s disease: Evidence and clinical implications[J]. Drug Alcohol Depend,2018,187:134-140. doi:10.1016/j.drugalcdep.2018.02.032. |
113 | KISH S J, BOILEAU I, CALLAGHAN R C, et al. Brain dopamine neurone ‘damage’: Methamphetamine users vs. Parkinson’s disease - a critical assessment of the evidence[J]. Eur J Neurosci,2017,45(1):58-66. doi:10.1111/ejn.13363. |
114 | KEVIL C G, GOEDERS N E, WOOLARD M D, et al. Methamphetamine use and cardiovascular disease[J]. Arterioscler Thromb Vasc Biol,2019,39(9):1739-1746. doi:10.1161/ATVBAHA.119.312461. |
115 | DARKE S, DUFLOU J, KAYE S. Prevalence and nature of cardiovascular disease in methamphetamine-related death: A national study[J]. Drug Alcohol Depend,2017,179:174-179. doi:10.1016/j.drugalcdep.2017.07.001. |
116 | REYNOLDS A R, STRICKLAND J C, STOOPS W W, et al. Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine[J]. Drug Alcohol Depend,2017,181:25-29. doi:10.1016/j.drugalcdep.2017.08.038. |
117 | CARVALHO M, CARMO H, COSTA V M, et al. Toxicity of amphetamines: An update[J]. Arch Toxicol,2012,86(8):1167-1231. doi:10.1007/s00204-012-0815-5. |
118 | RAMIREZ R L3RD, PEREZ V J, ZAMANIAN R T. Methamphetamine and the risk of pulmonary arterial hypertension[J]. Curr Opin Pulm Med,2018,24(5):416-424. doi:10.1097/mcp.0000000000000513. |
119 | 孙晓宇,王玉,李竹,等. 缝隙连接蛋白43及其S368位点磷酸化水平与甲基苯丙胺诱导的心肌毒性的关系[J].中国动脉硬化杂志,2019,27(5):374-380. doi:10.3969/j.issn.1007-3949.2019.05.003. |
SUN X Y, WANG Y, LI Z, et al. Relationship between connexin 43 and phosphorylation of its S368 site and methamphetamine induced myocardial toxicity[J]. Zhongguo Dongmai Yinghua Zazhi,2019,27(5):374-380. | |
120 | SUN X, WANG Y, XIA B, et al. Methampheta-mine produces cardiac damage and apoptosis by decreasing melusin[J]. Toxicol Appl Pharmacol,2019,378:114543. doi:10.1016/j.taap.2019.03.015. |
121 | 华楠,张玉荣,沈舜义. 毒品的快速检测方法开发及其应用[J].世界临床药物,2016,37(3):210-213. doi:10.13683/j.wph.2016.03.015. |
HUA N, ZHANG Y R, SHEN S Y. Development and application of rapid drug detection[J]. Shijie Linchuang Yaowu,2016,37(3):210-213. | |
122 | 郝红霞,白凤波. 甲基苯丙胺检测方法研究进展[J].分析试验室,2020,39(3):364-372. doi:10.13595/j.cnki.issn1000-0720.2019.110605. |
HAO H X, BAI F B. Advances in the detection of methamphetamine[J]. Fenxi Shiyanshi,2020,39(3):364-372. | |
123 | 魏万里. SPE-GC-MS/MS-SRM法快速检测尿液中12种常见毒品成分及代谢物[J].中国人民公安大学学报(自然科学版),2012,18(3):27-31. doi:10.3969/j.issn.1007-1784.2012.03.008. |
WEI W L. Rapid detection of 12 common drug components and metabolites in urine by SPE-GC-MS/MS-SRM[J]. Zhongguo Renmin Gongan Daxue Xuebao (Natural science edition),2012,18(3):27-31. | |
124 | YANG Y, WU J, DENG J, et al. Rapid and on-site analysis of amphetamine-type illicit drugs in whole blood and raw urine by slug-flow microextraction coupled with paper spray mass spectrometry[J]. Anal Chim Acta,2018,1032:75-82. doi:10.1016/j.aca.2018. |
06 | 006. |
125 | STEUER A E, SCHMIDHAUSER C, LIECHTI M E, et al. Development and validation of an LC-MS/MS method after chiral derivatization for the simultaneous stereoselective determination of methy-lenedioxy-methamphetamine (MDMA) and its phase Ⅰ and Ⅱ metabolites in human blood plasma[J]. Drug Test Anal,2015,7(7):592-602. doi:10.1002/dta.1740. |
126 | SHU I, ALEXANDER A, JONES M, et al. Determination of methamphetamine enantiomer composition in human hair by non-chiral liquid chro-matography-tandem mass spectrometry method[J]. J Chromatogr B Analyt Technol Biomed Life Sci,2016,1028:145-152. doi:10.1016/j.jchromb.2016.06.015. |
127 | 唐晓欢,吴天辉,孙荣基,等. 胶体金试纸法检测头发样本中吗啡和甲基苯丙胺的准确性及可靠性研究[J].国际药学研究杂志,2020,47(10):876-880. doi:10.13220/j.cnki.jipr.2020.10.018. |
TANG X H, WU T H, SUN R J, et al. The accuracy and reliability of colloidal gold lateral assay in detection of morphine and methamphetamine in hair samples[J]. Guoji Yaoxue Yanjiu Zazhi,2020,47(10):876-880. | |
128 | 赵绪龙,马广鹏,武继锋,等. 冷冻研磨结合LC-MS/MS法检测指甲中甲基苯丙胺、苯丙胺成分[J].刑事技术,2020,45(6):601-605. doi:10.16467/j.1008-3650.2020.06.011. |
ZHAO X L, MA G P, WU J F, et al. Determination of methamphetamine and amphetamine in nail through frozen grinding coupled into high performance liquid chromatography-tandem mass spectrometry[J]. Xingshi Jishu,2020,45(6):601-605. | |
129 | 吴元钊,吕云平,王继业. 基于表面等离子共振技术的毒品快检装备设计与开发[J].警察技术,2020(1):89-91. doi:10.3969/j.issn.1009-9875.2020.01.023. |
WU Y Z, LÜ Y P, WANG J Y. Design and development of drug rapid detection equipment based on surface plasmon resonance technology[J]. Jingcha Jishu,2020(1):89-91. | |
130 | MCGEEHAN J, DENNANY L. Electrochemiluminescent detection of methamphetamine and amphe-tamine[J]. Forensic Sci Int,2016,264:1-6. doi:10.1016/j.forsciint.2016.02.048. |
131 | WANG J, YAO W, MENG F, et al. A surface plasmon resonance immunoassay for the rapid analysis of methamphetamine in forensic oral fluid[J]. J Clin Lab Anal,2019,33(9):e22993. doi:10.1002/jcla.22993. |
132 | XUE W, TAN X, KHAING OO M K, et al. Rapid and sensitive detection of drugs of abuse in sweat by multiplexed capillary based immuno-biosensors[J]. Analyst,2020,145(4):1346-1354. doi:10.1039/c9an02498k. |
[1] | 李雯, 李豪喆, 陈琛, 蔡伟雄. 面部微表情分析技术在法医精神病学领域的研究现状及应用展望[J]. 法医学杂志, 2023, 39(5): 493-500. |
[2] | 王中华, 李淑瑾. 人类身高推断的分子生物学研究进展[J]. 法医学杂志, 2023, 39(5): 487-492. |
[3] | 陈璐, 周喆, 王升启. 陈旧骸骨DNA身份鉴定的法医学进展[J]. 法医学杂志, 2023, 39(5): 478-486. |
[4] | 曾勇, 邹冬华, 范颖, 徐晴, 陶陆阳, 陈忆九, 李正东. 人体血管有限元建模及生物力学的研究进展与法医学应用[J]. 法医学杂志, 2023, 39(5): 471-477. |
[5] | 陈建波, 郭影, 陈再勇, 鲍人辉, 孔繁荣. 钩吻中毒死亡法医学鉴定1例[J]. 法医学杂志, 2023, 39(5): 509-511. |
[6] | 范飞, 武娟, 邓振华. 听力学客观检测技术在法医临床学中的应用进展[J]. 法医学杂志, 2023, 39(4): 360-366. |
[7] | 向青青, 陈立方, 苏秦, 杜宇坤, 梁沛妍, 康晓东, 石河, 徐曲毅, 赵建, 刘超, 陈晓晖. 微生物群落演替在死亡时间推断中的研究进展[J]. 法医学杂志, 2023, 39(4): 399-405. |
[8] | 曹宇奇, 施妍, 向平, 郭寅龙. 机器学习辅助非靶向筛查策略用于芬太尼类物质识别鉴定的研究进展[J]. 法医学杂志, 2023, 39(4): 406-416. |
[9] | 李燃, 孙宏钰. 法医学亲缘关系鉴定方法和研究热点[J]. 法医学杂志, 2023, 39(3): 231-239. |
[10] | 马晓燕, 孙宏钰, 黎青. 常染色体STR三等位基因型在法医DNA分析中的研究进展[J]. 法医学杂志, 2023, 39(3): 240-246. |
[11] | 陈航, 胡婧, 乔正, 邓虹霄, 吕敏, 刘伟. 法医毒物领域生物基质标准物质的研究进展[J]. 法医学杂志, 2023, 39(2): 176-185. |
[12] | 高红艳, 刘光甫, 吴建, 陈鹏宇. 动物DNA分型及其在法医学中的研究进展[J]. 法医学杂志, 2023, 39(2): 161-167. |
[13] | 龙武, 瞿鹏飞, 马琳, 王蕊, 习严梅, 李玉华, 聂胜洁, 段婷, 杜进良, 唐雪, 赵静峰, 雷普平, 王跃兵. 一起云南不明原因猝死案件中4种野生菌的细胞毒性[J]. 法医学杂志, 2023, 39(2): 121-128. |
[14] | 程忠平, 刘燕飞, 徐兴敏, 莫耀南. 磁性纳米颗粒在法医学痕量分析中的应用进展[J]. 法医学杂志, 2023, 39(2): 168-175. |
[15] | 郝虹霞, 王亚辉, 周智露, 刘太昂, 陈瑾, 何宇亨, 万雷, 夏文涛. 膝关节MRI活体年龄推断研究进展[J]. 法医学杂志, 2023, 39(1): 66-71. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||